Webster, NY, United States of America

Lianping Xing

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lianping Xing: Innovator in Pharmaceutical Compositions

Introduction

Lianping Xing is a notable inventor based in Webster, NY, with a focus on pharmaceutical innovations. He holds two patents that contribute significantly to the field of medicine, particularly in treating conditions related to bone loss and inflammation.

Latest Patents

His latest patents include "Bortezomib conjugates and methods using same," which provides compositions and methods for controllable local delivery of a conjugate of bortezomib and a bisphosphonate to promote bone formation. This invention is particularly useful for treating subjects with diseases characterized by bone loss. Another significant patent is "Methods and compositions for treating inflammatory conditions," which outlines methods for treating inflammatory conditions in patients using a therapeutic agent that is a vascular endothelial growth factor receptor-3 (VEGFR-3) agonist.

Career Highlights

Lianping Xing has worked with reputable organizations such as the University of Rochester and Biovinc LLC. His contributions to these institutions have been instrumental in advancing research and development in pharmaceutical sciences.

Collaborations

Some of his notable coworkers include Brendan F Boyce and Edward M Schwarz, who have collaborated with him on various projects.

Conclusion

Lianping Xing's innovative work in pharmaceutical compositions showcases his commitment to improving medical treatments for bone loss and inflammatory conditions. His patents reflect a significant contribution to the field, highlighting his role as a leading inventor in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…